Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04931095 · ClinicalTrials.gov registry record · Phase 1

The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment

A Phase 1 study of Alcohol Intoxication and Cannabis Intoxication, sponsored by Johns Hopkins University.

Completed
Registry status
Phase 1
Development phase
60
Enrollment target
1
Study location

NCT04931095: Completed Phase 1 study of Alcohol Intoxication and Cannabis Intoxication, sponsored by Johns Hopkins University.

NCT04931095 is a Phase 1 study of Alcohol Intoxication and Cannabis Intoxication that has completed, run by Johns Hopkins University. The registered enrollment target is 60 participants, below the 344-participant average among 15 other Alcohol Intoxication trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04931095, a Phase 1 study of Alcohol Intoxication and Cannabis Intoxication, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
Phase 1
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the individual and interactive effects of oral cannabis and alcohol on subjective and behavioral measures of impairment.

Primary Outcome

Acute cognitive and behavioral impairment will be assessed with global impairment score (range 0-100) on the DRUID app (higher scores indicate greater impairment). Results are mean change from baseline.

Interventions

  • DRUG Alcohol
  • DRUG Cannabis

Study Locations (1)

Maryland

  • Johns Hopkins Behavioral Pharmacology Research Unit - Baltimore

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-02-17
Est. Completion 2025-08-15
Phase Phase 1
Johns Hopkins University

1,448 total trials

What the finished NCT04931095 record still lists

NCT04931095 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 344-participant average among 15 other Alcohol Intoxication trials with a reported enrollment target (83% lower).

The record links to 2 conditions, with Alcohol Intoxication appearing as the primary indexed condition, and to 2 interventions - of which Alcohol is the first listed.

NCT04931095 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT04931095 about?

NCT04931095 is a clinical study titled "The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment". This study will evaluate the individual and interactive effects of oral cannabis and alcohol on subjective and behavioral measures of impairment.

What is the current status of trial NCT04931095?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2022-02-17. Estimated completion is 2025-08-15.

What conditions does trial NCT04931095 study?

This clinical trial studies the following conditions: Alcohol Intoxication, Cannabis Intoxication.

What interventions are being tested in trial NCT04931095?

The interventions under investigation include: Alcohol (DRUG), Cannabis (DRUG).

Who is sponsoring clinical trial NCT04931095?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04931095 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Intoxication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04931095's enrollment target sits among peer trials

60 14th of 15 higher than 2 of 15 other Alcohol Intoxication trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alcohol Intoxication trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04931095, the US trial registry maintained by the National Library of Medicine. NCT04931095 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.